# Fabrazyme

NDC: 58468-0040
Generic name: AGALSIDASE BETA
Labeler / Manufacturer: Genzyme Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20081217

FDA application: BLA103979

## Active ingredients

- AGALSIDASE BETA: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58468-0040"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58468-0040
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=988513ab-b06f-4dd0-93f7-d2d4531dcce4